Log In
Print
BCIQ
Print
Print this Print this
 

EG-1962

  Manage Alerts
Collapse Summary General Information
Company Edge Therapeutics Inc.
DescriptionSustained-release injectable formulation of nimodipine, a generic calcium channel blocker, consisting of biodegradable microparticles delivered through a patient's existing external ventricular drain
Molecular Target Calcium channel
Mechanism of ActionCalcium channel blocker
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today